Product NDC: | 51672-4111 |
Proprietary Name: | Phenytoin Sodium |
Non Proprietary Name: | Phenytoin Sodium |
Active Ingredient(s): | 100 mg/1 & nbsp; Phenytoin Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4111 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040684 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060905 |
Package NDC: | 51672-4111-1 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-1) |
NDC Code | 51672-4111-1 |
Proprietary Name | Phenytoin Sodium |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-1) |
Product NDC | 51672-4111 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phenytoin Sodium |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20060905 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | PHENYTOIN SODIUM |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |